More Business Wire
View Older Stories View Newer Stories-
Gilead and Tubulis Enter Into Exclusive Option and License Agreement to Develop ADC Candidate for Select Solid Tumor Target
-
Energous Awarded Scalable Multi-Phase Contract With Fortune 10 Retailer
-
Genetic Immunity (GI) Leverages VectorBuilder Partnership to Power Phase 3 HIV Vaccine Trials
-
Bank of Bahrain and Kuwait Leads the Fight Against Financial Crime with SymphonyAI's Best-in-Class AI-Based Anti-Money Laundering and Customer Due Diligence SaaS Products
-
Anthem Blue Cross and Blue Shield, Cleveland Clinic Reach Collaborative, Multi-Year Network Participation Agreement
-
Customer Satisfaction with Digital Claims Process Surges as Insurance Carriers Load New Features onto Apps, J.D. Power Finds
-
Perion Announces Strategic Partnership with a360media to Boost Retail Media Technology for Premium Publishers such as Us Weekly, InTouch, and Life & Style
-
Amtech Systems to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on Monday, December 9, 2024
-
ReposiTrak Welcomes 50 New Produce Suppliers to Rapidly Expanding Food Traceability Network
-
Atropos Health Named to Inc.’s 2024 Best in Business List for AI + Data
-
Laser Photonics Expands Semiconductor Industry-Focused Product Line
-
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Autire Launches CPA Industry’s First Audit Solution with Automated Risk Assessment, Transforming 401(k) Audit Compliance
-
Everseen Achieves Key 2024 Milestones in Vision AI for Retail
-
Palantir Granted FedRAMP High Baseline Authorization
-
Accenture to Announce First-Quarter Fiscal 2025 Results
-
nShift: Logistics Costs Risk Cutting Into Black-Friday Profits as Carrier Rates Soar by 25%
-
Ryder Sets New Giving Record With $1.150 Million Donation to United Way
-
pOpshelf Announces Daily Deals This Holiday Season
-
Berkshire Hathaway Specialty Insurance Makes Executive & Professional Lines Appointments in the UK
-
FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Ca
-
Citi Trends Announces Third Quarter Fiscal 2024 Results
-
Mirion to Detail Financial Targets and Long-term Strategy at Today’s Investor Day
-
Spire Global Appoints Theresa Condor as CEO and Taps Aerospace Industry Veterans for Executive Team
-
Arizona Sonoran Granted Amended Industrial Air Permit and Completes Local Polling with 87% Support for the Cactus Project
-
Matador Resources Company Increases Borrowing Base Under Matador Credit Facility and Lender Commitments Under San Mateo Credit Facility
-
Premier, Inc. Appoints David Zito as President, Performance Services
-
Maze Therapeutics Announces Oversubscribed $115 Million Financing to Support Advancement of Clinical-Stage Programs and Future Pipeline
-
Chimera Investment Corporation Completes Acquisition of Palisades Group
-
Flight Mobile Launches at Antietam Broadband
-
Wipro and Netskope Partner to Offer Cybersecurity Optimization Advisory Services
-
Peraton Awarded $249M LSOV Task Order
-
ServiceTitan Announces Launch of Initial Public Offering
-
Donaldson Reports Record First Quarter Fiscal 2025 Sales and Earnings
-
Emerging Cybersecurity Threats May Come From Unexpected Sources as Teens and AI-Savvy Employees May Perpetrate More Attacks Next Year
-
Monroe Capital Supports Shamrock Capital’s Acquisition of DE-YAN
-
Netcracker Honored With Frost & Sullivan Global OSS/BSS Industry Leadership Award
-
BlackRock to Acquire HPS Investment Partners to Deliver Integrated Solutions Across Public and Private Markets
-
Joby Receives FAA Approval for Part 141 Flight Academy
-
Cyware Launches Industry-Tuned Threat Intelligence Platform to Defend Healthcare Organizations from Cyber Threats
-
Push Security Transforms Threat Intelligence Analysis With New Verified Stolen Credentials Detection Capability
-
4M Building Solutions Acquires Covenant Building Service
-
Driven by Growth, Kleinfelder Announces Executive Leadership Team Promotions
-
Growth at AmericanTCS and NewEdge Capital Group Drive Parent Company EdgeCo Holdings Past $600 Billion in Assets Serviced
-
Pentair Acquires G&F Manufacturing, LLC
-
Genethon and Hansa Biopharma Announce Initiation of a Phase 2 Trial of imlifidase as a Pre-Treatment to GNT-0003 in Severe Crigler-Najjar Syndrome
-
Atom Therapeutics and China Medical System Holdings Enter Exclusive Commercialization Agreement for Lingdolinurad (ABP-671) to Treat Chronic Gout and Hyperuricemia
-
Airdrop Gaming and Logitech G Partner to Bring an Immersive Experience to Gamers That Are Deaf and Hard of Hearing
-
Jason Passwaters Honored on D CEO Dallas 500 List
-
MCO (MyComplianceOffice) wins the Financial Services Ireland Innovation Award in the 2024 Deloitte Technology Fast 50

